甲状腺疾病中的肥胖治疗应何时开始？
When Should the Treatment of Obesity in Thyroid Disease Begin?
作者信息
Sutkowska Edyta, Kisiel Michał, Zubkiewicz-Kucharska Agnieszka
机构信息
Department of Clinical Physiotherapy and Rehabilitation, Faculty of Physiotherapy, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.
出版信息
Biomedicines. 2025 Jan 10;13(1):157. doi: 10.3390/biomedicines13010157.
Abstract
Obesity often coexists with thyroid diseases, and the prevalence of these disorders has been on the rise for years. While hypothyroidism can contribute to excess fat tissue, the relationship between Body Mass Index (BMI) and thyroid function hormones is bidirectional. Research confirms that fat tissue reduction can positively impact thyroid function. Thus, delaying the initiation of therapies beyond substitution treatment to achieve optimal weight reduction in individuals with thyroid dysfunction seems unwarranted. The authors summarize current knowledge on this topic in the article.
摘要
肥胖常与甲状腺疾病并存，且这些疾病的患病率多年来一直在上升。虽然甲状腺功能减退会导致脂肪组织过多，但体重指数（BMI）与甲状腺功能激素之间的关系是双向的。研究证实，减少脂肪组织对甲状腺功能有积极影响。因此，对于甲状腺功能障碍患者，推迟开始替代治疗以外的疗法以实现最佳体重减轻似乎没有必要。作者在文章中总结了关于这一主题的现有知识。
相似文献
1
When Should the Treatment of Obesity in Thyroid Disease Begin?甲状腺疾病中的肥胖治疗应何时开始？
Biomedicines. 2025 Jan 10;13(1):157. doi: 10.3390/biomedicines13010157.
2
3
Influence of obesity and surgical weight loss on thyroid hormone levels.肥胖及手术减肥对甲状腺激素水平的影响。
Surg Obes Relat Dis. 2007 Nov-Dec;3(6):631-5; discussion 635-6. doi: 10.1016/j.soard.2007.07.011.
4
Thyroid hormone and obesity.甲状腺激素与肥胖。
Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):408-13. doi: 10.1097/MED.0b013e328355cd6c.
5
Associations Between Thyroid Hormones Within the Euthyroid Range and Indices of Obesity in Obese Chinese Women of Reproductive Age.甲状腺激素在正常范围内与肥胖中国育龄妇女肥胖指数之间的关联。
Metab Syndr Relat Disord. 2019 Oct;17(8):416-422. doi: 10.1089/met.2019.0036. Epub 2019 Jul 29.
6
Impact of Laboratory-Measured Euthyroid Hashimoto's Thyroiditis on Reproductive Hormone Profile in Women with Obesity.实验室检测的亚临床型桥本甲状腺炎对肥胖女性生殖激素谱的影响。
Metab Syndr Relat Disord. 2025 May;23(4):211-216. doi: 10.1089/met.2024.0181. Epub 2024 Dec 10.
7
Association between different metabolic phenotypes of obesity and thyroid disorders among Chinese adults: a nationwide cross-sectional study.肥胖不同代谢表型与中国成年人甲状腺疾病的关系：一项全国性横断面研究。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1158013. doi: 10.3389/fendo.2023.1158013. eCollection 2023.
8
The determinants of leptin, angiopoietin like 8, and thyroid hormones levels in Saudi females with type 2 diabetes mellitus: A retrospective study.沙特 2 型糖尿病女性瘦素、血管生成素样蛋白 8 和甲状腺激素水平的决定因素：一项回顾性研究。
Medicine (Baltimore). 2024 Sep 6;103(36):e39339. doi: 10.1097/MD.0000000000039339.
9
Association between thyroid hormones and body fat in euthyroid subjects.甲状腺激素与甲状腺功能正常者体脂的关系。
Clin Endocrinol (Oxf). 2014 Apr;80(4):585-90. doi: 10.1111/cen.12311. Epub 2013 Sep 23.
10
Thyroid disease and autoimmunity in obese patients: a narrative review.肥胖患者的甲状腺疾病与自身免疫：叙述性综述。
Endokrynol Pol. 2023;74(6). doi: 10.5603/ep.96255. Epub 2023 Nov 23.
引用本文的文献
1
Beyond the skin: endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa.超越皮肤层面：化脓性汗腺炎女性患者的内分泌、心理及营养方面
J Transl Med. 2025 Feb 10;23(1):167. doi: 10.1186/s12967-025-06175-1.
本文引用的文献
1
Lifestyle Intervention Requirements for Novel Antiobesity Medications-Necessary Adjunct or Harmful Gatekeeper?新型抗肥胖药物的生活方式干预要求——必要辅助手段还是有害守门人？
JAMA Intern Med. 2025 Mar 1;185(3):255-256. doi: 10.1001/jamainternmed.2024.6450.
2
Impaired Sensitivity to Thyroid Hormones is Associated with Central Obesity in Euthyroid Type 2 Diabetes Mellitus Patients with Overweight and Obesity.甲状腺激素敏感性受损与超重和肥胖的甲状腺功能正常的2型糖尿病患者的中心性肥胖有关。
Diabetes Metab Syndr Obes. 2024 Sep 11;17:3379-3396. doi: 10.2147/DMSO.S472550. eCollection 2024.
3
The Effect of Mediterranean Diet on Thyroid Gland Activity.地中海饮食对甲状腺活动的影响。
Int J Mol Sci. 2024 May 28;25(11):5874. doi: 10.3390/ijms25115874.
4
Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.胰高血糖素样肽 1 受体激动剂的使用与甲状腺癌风险：斯堪的纳维亚队列研究。
BMJ. 2024 Apr 10;385:e078225. doi: 10.1136/bmj-2023-078225.
5
5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study.英国减肥维持持续支持随机糖尿病缓解临床试验（DiRECT）的 5 年随访：一项扩展研究。
Lancet Diabetes Endocrinol. 2024 Apr;12(4):233-246. doi: 10.1016/S2213-8587(23)00385-6. Epub 2024 Feb 26.
6
Causal association between obesity and hypothyroidism: a two-sample bidirectional Mendelian randomization study.肥胖与甲状腺功能减退症之间的因果关系：两样本双向孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 Jan 8;14:1287463. doi: 10.3389/fendo.2023.1287463. eCollection 2023.
7
Effect of physical exercise in people with hypothyroidism: systematic review and meta-analysis.运动对甲状腺功能减退症患者的影响：系统评价和荟萃分析。
Scand J Clin Lab Invest. 2023 Dec;83(8):523-532. doi: 10.1080/00365513.2023.2286651. Epub 2024 Jan 24.
8
The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.GLP-1RAs 胰高血糖素样肽-1 受体激动剂在超重或肥胖的非糖尿病患者中的减肥效果：一项随机对照试验的系统评价和荟萃分析及试验序贯分析。
Am J Clin Nutr. 2023 Sep;118(3):614-626. doi: 10.1016/j.ajcnut.2023.04.017. Epub 2023 Aug 8.
9
Effects of levothyroxine substitution therapy on hunger and food intake in individuals with hypothyroidism.左甲状腺素替代疗法对甲状腺功能减退症患者饥饿感和食物摄入量的影响。
Endocr Connect. 2023 Sep 19;12(10). doi: 10.1530/EC-23-0314. Print 2023 Oct 1.
10
Outcomes at 10-Year Follow-Up after Roux-en-Y Gastric Bypass, Biliopancreatic Diversion, and Sleeve Gastrectomy.Roux-en-Y胃旁路术、胆胰转流术和袖状胃切除术10年随访结果。
J Clin Med. 2023 Jul 28;12(15):4973. doi: 10.3390/jcm12154973.
Zotero 插件